Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: EULAT Eradicate GBC

View source ↗

Summary

A clinical trial update indicates the study NCT06192719 titled 'EULAT Eradicate GBC' is currently recruiting to evaluate treatment for gallbladder cancer. Galls…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Paul Strauss | Conditions: Gallbladder Cancer, Gallstone Disease | Status: RECRUITING